Corin Share Discussion Threads

[steeplejack] 08/10/2004 10:45

Could be someone like Johnson & Johnson but that's a pure guess, someone
US seems likely.Next year eps consensus around 12p puts stock on exit
multiple of over 30x and bearing in mind that Smith & Nephew is on a PE of
around 20x,well there's your 50% premium so i don't think there's much
left to go for.

[holidayfunds] 08/10/2004 10:05

very difficult to say, but a premium of at least 50% on 300pence might go through. So that would give 450pence. But, really, I have no idea; Corin's management know the inside story here re likely US sales development and, if the bidder is located in the US, then they may also be pretty well clued up; so shareholders may benefit from such well-informed views, in such an agreed offer scenario...

HF

[mdchand] 08/10/2004 09:56

no mention on recent rns??? anyone got an idea of fair value on this stock or indeed, who might be stalking?

[holidayfunds] 07/10/2004 16:36

yep, good stuff

[steeplejack] 07/10/2004 16:20

NO but i'd like the stock back i sold last week.This stock has been
in bit of a trading range of late but this is a real breakout.

[fairdinkum] 07/10/2004 16:06

Big rise today. Anybody know what's going on?

[clairvoyant1] 27/9/2004 12:58

someone mentioned the other day a similar sort of comp was taken over at a subst premium a while ago

[holidayfunds] 23/9/2004 08:38

yep, steady trading improvement for now, but the potential jewel here that has captured attention is the USA, now just over 10% of total sales, but growing pretty quickly (+91% YOY).

However, if Cormet (hip replacement) and other products can gain US approval (and this looks pretty likely), the financial impact will be significant.

A year plus away yet, though; but then again, if things in the US do develop as expected, Corin will command a much higher mkt valuation once these additional income flows are secured. So my guess is that shareholders will see pretty decent returns as visibility here improves.

David

[clairvoyant1] 23/9/2004 08:37

rumour of bid as well

[steeplejack] 23/9/2004 07:53

Well,since there's no one else about....i pronounce these interim
figures much in line with best expectations.Good improvement in
margins with a pleasing build-up in infrastructure for the all
important push into the USA in 2006.Good solid buy and GL to all who
sail in her.

[fairdinkum] 13/9/2004 11:18

Fair bit of buying of these going on. What does the market know, maybe some good results coming up?

[shirishg] 06/9/2004 09:36

Post removed by ADVFN

[paladin12001] 27/8/2004 13:32

See a M trade has gone through today, only 2000, but someones short of stock me tinks! Another tick up on the way?

[holidayfunds] 25/8/2004 15:36

Just grossly under-valued, given the likely growth rates from here.

And already nicely profitable.

HF

[paladin12001] 24/8/2004 11:16

Any thoughts on the renewed interest in CRG? nice tick ups, any news?

[surfcontrol] 14/8/2004 11:18

Takeover bid for Surfcontrol (SRF) imminent...

Current Surfcontrol price : 520p (market cap. £160m / $295m)

Prospective Takeover Bid : 730p (Cash bid of £225m / $415m)

Bid Premium : 210p (+ 40%)

Bid Timing : Before Surfcontrol Q4 results on 7th September

Bidder : Advised by Deutsche Bank / Goldman Sachs

[steeplejack] 12/8/2004 12:28

Healthcare stocks have been weak on the Street and Smith & Nephew disappointed,
so by association, in light trading, Corin retreats.Good long term hold.

[explorer88] 07/8/2004 13:18

Check out OMG (www.omg3d.com / www.vicon.com)

With world class products, new markets opening up and cash available for further acquisitions, we expect OMG's turnover to increase dramatically in the next twelve months. Our fair value price targets for OMG are:

July 2005 : 52p (market cap. £28 million) + 116% on current level
July 2006 : 91p (market cap. £49 million) + 279% on current level

Current Price : 24p (market cap. £13 million)

Siggraph event starting Monday 9th August will generate significant sales for new MX system

[chaweewan] 04/8/2004 19:05

Well I hope that Artemis know what they are doing. They are part of my ISA.
No company news to account for the downward trend of the shares. Any comment anyone?

[paladin12001] 28/7/2004 16:44

Company Corin Group PLC
TIDM CRG
Headline Holding(s) in Company
Released 16:34 28-Jul-04
Number 3324B



RNS Number:3324B
Corin Group PLC
28 July 2004



Corin Group PLC (the "Company")

Notifiable Interest

The Company was notified on 27 July 2004 that, Artemis Investment Management
Limited and certain of its subsidiary companies have a notifiable interest in
1,710,288 ordinary shares of 2.5p each ("Ordinary Shares") in the Company. These
Ordinary Shares represent 4.44 per cent. of the issued Ordinary Share capital.
The beneficial owner of the above interest is Artemis Smaller Companies Fund.

28 July 2004




This information is provided by RNS
The company news service from the London Stock Exchange

END

[paladin12001] 28/7/2004 11:22

No trades as yet today...any ideas why it's so quiet?

[keifer derrin] 25/6/2004 08:08

Corin Group PLC
25 June 2004


Corin Group Plc

AGM Statement



Corin Group PLC ('Corin' or 'the Group'), a leading innovative developer,
manufacturer and global distributor of a wide range of reconstructive
orthopaedic devices, is holding its AGM later this morning. The Chairman of
Corin, Graeme Hart, will make the following statement.


'The Group continues to trade in line with the Board's expectations. Our USA
business, in particular, is having a positive first half, as the distribution
channels developed over the last 12 months begin to bear fruit.


'We are also encouraged by the outcome of a recent FDA panel meeting.
Shareholders will recall that Corin is currently pursuing an FDA approved
clinical trial relating to its Rotaglide + mobile bearing knee system for which
approval has been anticipated to be granted in 2007/8.


'Earlier this month, an FDA panel voted in favour of an industry proposal to
down-classify both total and unicondylar mobile bearing knees and their
recommendation has now been passed through to the FDA for approval. If
approved, it would eliminate the need for a lengthy clinical trial to achieve
product approval.


'Corin believes it is likely that a down-classification of mobile bearing knees
will occur, although the FDA has not confirmed the likely time scale. However,
the Group does anticipate that it will have the opportunity to sell both the
Rotaglide + total knee and the AMC Uniglide unicondylar knee in the USA earlier
than previously expected.'


25 June 2004

Enquiries:

Corin Group PLC 01285 659866
Ian Paling, Chief Executive
Simon Hartley, Finance Director

College Hill 020 7457 2020
Adrian Duffield
Clare Warren


This information is provided by RNS
The company news service from the London Stock Exchange

[keifer derrin] 23/6/2004 16:43

thanks for that scallyway. Now if we can just have a few more......

[scallywag] 23/6/2004 16:24

Tipped by Quantum Leap - a newsletter / tipsheet

[keifer derrin] 23/6/2004 14:41

anybody know why the big jump today????